Retinal Biosimilars Market Report

Global and Region Retinal Biosimilars Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：228
  • REPORT CODE：GMM930666
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Retinal Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Retinal Biosimilarsmarket, defines the market attractiveness level of Retinal Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Retinal Biosimilars industry, describes the types of Retinal Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global Retinal Biosimilars market and the development prospects and opportunities of Retinal Biosimilars industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Retinal Biosimilars market in Chapter 13.

    By Player:

    • Intas Pharmaceuticals

    • Hetero Drugs

    • Santo Holding

    • Bayer

    • Pfenex

    • Takeda

    • Genentech

    • Reliance Life Sciences

    • Regeneron Pharmaceuticals

    • Novartis (Sandoz)

    By Type:

    • Macular Degeneration Drugs

    • Diabetic Eye Disease Drugs

    • Macular Pucker Drugs

    • Others

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Retinal Biosimilars Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Retinal Biosimilars Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Retinal Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Retinal Biosimilars Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Retinal Biosimilars Market Analysis and Outlook to 2022

    • 7.1 Global Retinal Biosimilars Consumption (2017-2022)

    • 7.2 United States Retinal Biosimilars Consumption (2017-2022)

    • 7.3 Europe Retinal Biosimilars Consumption (2017-2022)

    • 7.4 China Retinal Biosimilars Consumption (2017-2022)

    • 7.5 Japan Retinal Biosimilars Consumption (2017-2022)

    • 7.6 India Retinal Biosimilars Consumption (2017-2022)

    • 7.7 South Korea Retinal Biosimilars Consumption (2017-2022)

    8 Region and Country-wise Retinal Biosimilars Market Analysis and Outlook to 2028

    • 8.1 Global Retinal Biosimilars Consumption Forecast (2022-2028)

    • 8.2 United States Retinal Biosimilars Consumption Forecast (2022-2028)

    • 8.3 Europe Retinal Biosimilars Consumption Forecast (2022-2028)

    • 8.4 China Retinal Biosimilars Consumption Forecast (2022-2028)

    • 8.5 Japan Retinal Biosimilars Consumption Forecast (2022-2028)

    • 8.6 India Retinal Biosimilars Consumption Forecast (2022-2028)

    • 8.7 South Korea Retinal Biosimilars Consumption Forecast (2022-2028)

    9 Global Retinal Biosimilars Market Outlook by Types and Applications to 2022

    • 9.1 Global Retinal Biosimilars Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Diabetic Eye Disease Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Macular Pucker Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Retinal Biosimilars Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Retinal Biosimilars Market Outlook by Types and Applications to 2028

    • 10.1 Global Retinal Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Diabetic Eye Disease Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Macular Pucker Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Retinal Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Retinal Biosimilars Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Retinal Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Retinal Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Retinal Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Retinal Biosimilars Market Competitive Analysis

    • 14.1 Intas Pharmaceuticals

      • 14.1.1 Intas Pharmaceuticals Company Details

      • 14.1.2 Intas Pharmaceuticals Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Intas Pharmaceuticals Retinal Biosimilars Product and Service

    • 14.2 Hetero Drugs

      • 14.2.1 Hetero Drugs Company Details

      • 14.2.2 Hetero Drugs Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Hetero Drugs Retinal Biosimilars Product and Service

    • 14.3 Santo Holding

      • 14.3.1 Santo Holding Company Details

      • 14.3.2 Santo Holding Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Santo Holding Retinal Biosimilars Product and Service

    • 14.4 Bayer

      • 14.4.1 Bayer Company Details

      • 14.4.2 Bayer Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bayer Retinal Biosimilars Product and Service

    • 14.5 Pfenex

      • 14.5.1 Pfenex Company Details

      • 14.5.2 Pfenex Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfenex Retinal Biosimilars Product and Service

    • 14.6 Takeda

      • 14.6.1 Takeda Company Details

      • 14.6.2 Takeda Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Takeda Retinal Biosimilars Product and Service

    • 14.7 Genentech

      • 14.7.1 Genentech Company Details

      • 14.7.2 Genentech Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Genentech Retinal Biosimilars Product and Service

    • 14.8 Reliance Life Sciences

      • 14.8.1 Reliance Life Sciences Company Details

      • 14.8.2 Reliance Life Sciences Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Reliance Life Sciences Retinal Biosimilars Product and Service

    • 14.9 Regeneron Pharmaceuticals

      • 14.9.1 Regeneron Pharmaceuticals Company Details

      • 14.9.2 Regeneron Pharmaceuticals Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Regeneron Pharmaceuticals Retinal Biosimilars Product and Service

    • 14.10 Novartis (Sandoz)

      • 14.10.1 Novartis (Sandoz) Company Details

      • 14.10.2 Novartis (Sandoz) Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis (Sandoz) Retinal Biosimilars Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Retinal Biosimilars

    • Figure Retinal Biosimilars Picture

    • Table Global Retinal Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Retinal Biosimilars Consumption by Country (2017-2022)

    • Figure United States Retinal Biosimilars Consumption and Growth Rate (2017-2022)

    • Table Europe Retinal Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure China Retinal Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Japan Retinal Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure India Retinal Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure South Korea Retinal Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global Retinal Biosimilars Consumption Forecast by Country (2022-2028)

    • Figure United States Retinal Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Retinal Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Retinal Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Retinal Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Retinal Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Retinal Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetic Eye Disease Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Macular Pucker Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetic Eye Disease Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Macular Pucker Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Retinal Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Retinal Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    • Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Intas Pharmaceuticals Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intas Pharmaceuticals Retinal Biosimilars Product and Service

    • Table Hetero Drugs (Foundation Year, Company Profile and etc.)

    • Table Hetero Drugs Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hetero Drugs Retinal Biosimilars Product and Service

    • Table Santo Holding (Foundation Year, Company Profile and etc.)

    • Table Santo Holding Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Santo Holding Retinal Biosimilars Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Retinal Biosimilars Product and Service

    • Table Pfenex (Foundation Year, Company Profile and etc.)

    • Table Pfenex Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfenex Retinal Biosimilars Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Retinal Biosimilars Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Retinal Biosimilars Product and Service

    • Table Reliance Life Sciences (Foundation Year, Company Profile and etc.)

    • Table Reliance Life Sciences Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reliance Life Sciences Retinal Biosimilars Product and Service

    • Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Retinal Biosimilars Product and Service

    • Table Novartis (Sandoz) (Foundation Year, Company Profile and etc.)

    • Table Novartis (Sandoz) Retinal Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis (Sandoz) Retinal Biosimilars Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US